Literature DB >> 28273390

Purpureocillium lilacinum tattoo-related skin infection in a kidney transplant recipient.

Sonya A Trinh1, Michael P Angarone1.   

Abstract

Purpureocillium lilacinum is an emerging pathogenic mold among immunocompromised hosts that causes cutaneous infections related to skin breakdown. We present the first reported case of P. lilacinum tattoo-related skin infection, to our knowledge. A kidney transplant recipient recently treated for acute cellular rejection presented with skin papules overlying a tattoo. Diagnosis was confirmed on culture, histology, and 18S ribosomal RNA polymerase chain reaction. The morphological features on culture characteristic of P. lilacinum included violet colonies on malt extract agar, long tapering brush-like phialides, and elliptical conidia attached in chains. P. lilacinum has intrinsic resistance to many antifungal agents including amphotericin B, but voriconazole and posaconazole have good in vitro activity. The patient was treated with voriconazole with subsequent resolution of the papules after 3 months of therapy.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Paecilomyceszzm321990; zzm321990Purpureocilliumzzm321990; solid organ transplant; tattoo

Mesh:

Substances:

Year:  2017        PMID: 28273390      PMCID: PMC5547740          DOI: 10.1111/tid.12689

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  10 in total

1.  Purpureocillium, a new genus for the medically important Paecilomyces lilacinus.

Authors:  Jennifer Luangsa-Ard; Jos Houbraken; Tineke van Doorn; Seung-Beom Hong; Andrew M Borman; Nigel L Hywel-Jones; Robert A Samson
Journal:  FEMS Microbiol Lett       Date:  2011-06-23       Impact factor: 2.742

Review 2.  Paecilomyces lilacinus fungemia in an adult bone marrow transplant recipient.

Authors:  K M Chan-Tack; C L Thio; N S Miller; C L Karp; C Ho; W G Merz
Journal:  Med Mycol       Date:  1999-02       Impact factor: 4.076

3.  Outbreak of invasive mycoses caused by Paecilomyces lilacinus from a contaminated skin lotion.

Authors:  B Orth; R Frei; P H Itin; M G Rinaldi; B Speck; A Gratwohl; A F Widmer
Journal:  Ann Intern Med       Date:  1996-11-15       Impact factor: 25.391

Review 4.  Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections.

Authors:  F J Pastor; J Guarro
Journal:  Clin Microbiol Infect       Date:  2006-10       Impact factor: 8.067

Review 5.  Cutaneous manifestations of Paecilomyces lilacinus infection induced by a contaminated skin lotion in patients who are severely immunosuppressed.

Authors:  P H Itin; R Frei; S Lautenschlager; S A Buechner; C Surber; A Gratwohl; A F Widmer
Journal:  J Am Acad Dermatol       Date:  1998-09       Impact factor: 11.527

Review 6.  Neglected and emerging fungal infections: review of hyalohyphomycosis by Paecilomyces lilacinus focusing in disease burden, in vitro antifungal susceptibility and management.

Authors:  Paulo R Z Antas; Marcelly M S Brito; Érika Peixoto; Carlos G G Ponte; Cíntia M Borba
Journal:  Microbes Infect       Date:  2011-08-30       Impact factor: 2.700

Review 7.  Use of voriconazole for the treatment of Paecilomyces lilacinus cutaneous infections: case presentation and review of published literature.

Authors:  Ramzy H Rimawi; Yvonne Carter; Thomas Ware; John Christie; Dawd Siraj
Journal:  Mycopathologia       Date:  2013-01-20       Impact factor: 2.574

8.  Paecilomyces lilacinus catheter-related fungemia in an immunocompromised pediatric patient.

Authors:  T Q Tan; A K Ogden; J Tillman; G J Demmler; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

9.  Susceptibility testing and molecular classification of Paecilomyces spp.

Authors:  Maria Victoria Castelli; Ana Alastruey-Izquierdo; Isabel Cuesta; Araceli Monzon; Emilia Mellado; Juan L Rodriguez-Tudela; Manuel Cuenca-Estrella
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

10.  The use of real-time PCR and species-specific primers for the identification and monitoring of Paecilomyces lilacinus.

Authors:  Simon D Atkins; Ian M Clark; Sonal Pande; Penny R Hirsch; Brian R Kerry
Journal:  FEMS Microbiol Ecol       Date:  2005-01-01       Impact factor: 4.194

  10 in total
  7 in total

1.  Unusual complication of a tattoo in an immunosuppressed patient.

Authors:  William Thomas Wilson; Mannix O'Boyle; William J Leach
Journal:  BMJ Case Rep       Date:  2018-06-18

Review 2.  Human Pathogenic Paecilomyces from Food.

Authors:  Danielly C Moreira; Manoel M E Oliveira; Cintia M Borba
Journal:  Microorganisms       Date:  2018-07-05

3.  Atypical Fungal Rash.

Authors:  Fadi W M Adel; Venkatesh Bellamkonda
Journal:  Clin Pract Cases Emerg Med       Date:  2019-02-26

4.  Tinea and Tattoo: A Man Who Developed Tattoo-Associated Tinea Corporis and a Review of Dermatophyte and Systemic Fungal Infections Occurring Within a Tattoo.

Authors:  Philip R Cohen; Christopher S Crowley; Christof P Erickson; Antoanella Calame
Journal:  Cureus       Date:  2022-01-13

5.  Diagnostic and therapeutic challenges of treating opportunistic fungal cellulitis: a case series.

Authors:  Jed Paul; Mary M Czech; Ramya Balijepally; Janice Wes Brown
Journal:  BMC Infect Dis       Date:  2022-05-05       Impact factor: 3.667

6.  Chronic subcutaneous infection of Purpureocillium lilacinum in an immunocompromised patient: Case report and review of the literature.

Authors:  Robin Albert; Adrien Lemaignen; Guillaume Desoubeaux; Eric Bailly; Louis Bernard; Marion Lacasse
Journal:  Med Mycol Case Rep       Date:  2022-09-03

7.  Isavuconazonium for the treatment of Purpureocillium lilacinum infection in a patient with pyoderma gangrenosum.

Authors:  Julia Accetta; Emily Powell; Erin Boh; Lisa Bull; Abida Kadi; Alfred Luk
Journal:  Med Mycol Case Rep       Date:  2020-05-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.